Derivatives	12 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	Note 11. Derivatives We manage exposure to changes in market interest rates. Our use of derivative instruments is limited to highly effective interest rate swaps to hedge the risk of changes in cash flows (future interest payments) attributable to changes in LIBOR swap rates, with the designated benchmark interest rate being hedged on certain of our LIBOR indexed variable rate debt and a variable rate operating lease. The interest rate swaps effectively fix our interest payments on certain LIBOR indexed variable rate debt. We monitor our positions and the credit ratings of its counterparties and do not currently anticipate non-performance by the counterparties. Interest rate swap agreements are not entered into for trading purposes. These fair values are determined using pricing valuation models which include broker quotes for which significant inputs are observable. They include adjustments for counterparty credit quality and other deal-specific factors, where appropriate and are classified as Level 2 in the fair value hierarchy. The derivative fair values reflected in prepaid expense and accounts payable and accrued expenses in the consolidated balance sheet were as follows: March 31, 2020 March 31, 2019 (In thousands) Interest rate contracts designated as hedging instruments Assets $ – $ 139 Liabilities 8,214 – Notional amount (debt) 235,000 22,792 F- 26 amerco and consolidated subsidiaries notes to consolidated financial statements – (continued) The Effect of Interest Rate Contracts on the Statements of Operations Years Ended March 31, 2020 2019 2018 (In thousands) (Gain) loss recognized in AOCI on interest rate contracts $ 8,356 $ (633) $ (4,445) (Gain) loss reclassified from AOCI into income $ (401) $ 789 $ 3,893 Gains or losses recognized in income on derivatives are recorded as interest expense in the consolidated statements of operations. During fiscal year 2020, we recognized a decrease in the fair value of our cash flow hedges of $ 6.3 million, net of taxes. During fiscal year 2020, we reclassified $ 0.4 million from accumulated other comprehensive income (loss) (“AOCI”) to interest expense. As of March, 31 2020, we expect to reclassify $ 0.4 million of net gains on interest contracts from AOCI to earnings as interest expense over the next twelve months. We use derivatives to hedge our equity market exposure to indexed annuity products sold by our Life Insurance company. These contracts earn a return for the contractholder based on the change in the value of the S&P 500 index between annual index point dates. We buy and sell listed equity and index call options and call option spreads. The credit risk is with the party in which the options are written. The net option price is paid up front and there are no additional cash requirements or additional contingent liabilities. These contracts are held at fair market value on our balance sheet. At March 31, 2020 and 2019, these derivative hedges had a net market value of $ 5.9 million and $ 1.5 million, with notional amounts of $ 246.8 million and $ 284.0 million, respectively. These derivative instruments are included in Investments, other; on the consolidated balance sheets. The fair values of these call options are determined based on quoted market prices from the relevant exchange and are classified as Level 1 in the fair value hierarchy. Although the call options are employed to be effective hedges against our policyholder obligations from an economic standpoint, they do not meet the requirements for hedge accounting under GAAP. Accordingly, the call options are marked to fair value on each reporting date with the change in fair value, plus or minus, included as a component of net investment and interest income. The change in fair value of the call options include the gains or losses recognized at the expiration of the option term and the changes in fair value for open contracts.

Derivatives

12 Months Ended

Mar. 31, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Note 11. Derivatives We manage exposure to changes in market interest rates. Our use of derivative instruments is limited to highly effective interest rate swaps to hedge the risk of changes in cash flows (future interest payments) attributable to changes in LIBOR swap rates, with the designated benchmark interest rate being hedged on certain of our LIBOR indexed variable rate debt and a variable rate operating lease. The interest rate swaps effectively fix our interest payments on certain LIBOR indexed variable rate debt. We monitor our positions and the credit ratings of its counterparties and do not currently anticipate non-performance by the counterparties. Interest rate swap agreements are not entered into for trading purposes. These fair values are determined using pricing valuation models which include broker quotes for which significant inputs are observable. They include adjustments for counterparty credit quality and other deal-specific factors, where appropriate and are classified as Level 2 in the fair value hierarchy. The derivative fair values reflected in prepaid expense and accounts payable and accrued expenses in the consolidated balance sheet were as follows: March 31, 2020 March 31, 2019 (In thousands) Interest rate contracts designated as hedging instruments Assets $ – $ 139 Liabilities 8,214 – Notional amount (debt) 235,000 22,792 F- 26 amerco and consolidated subsidiaries notes to consolidated financial statements – (continued) The Effect of Interest Rate Contracts on the Statements of Operations Years Ended March 31, 2020 2019 2018 (In thousands) (Gain) loss recognized in AOCI on interest rate contracts $ 8,356 $ (633) $ (4,445) (Gain) loss reclassified from AOCI into income $ (401) $ 789 $ 3,893 Gains or losses recognized in income on derivatives are recorded as interest expense in the consolidated statements of operations. During fiscal year 2020, we recognized a decrease in the fair value of our cash flow hedges of $ 6.3 million, net of taxes. During fiscal year 2020, we reclassified $ 0.4 million from accumulated other comprehensive income (loss) (“AOCI”) to interest expense. As of March, 31 2020, we expect to reclassify $ 0.4 million of net gains on interest contracts from AOCI to earnings as interest expense over the next twelve months. We use derivatives to hedge our equity market exposure to indexed annuity products sold by our Life Insurance company. These contracts earn a return for the contractholder based on the change in the value of the S&P 500 index between annual index point dates. We buy and sell listed equity and index call options and call option spreads. The credit risk is with the party in which the options are written. The net option price is paid up front and there are no additional cash requirements or additional contingent liabilities. These contracts are held at fair market value on our balance sheet. At March 31, 2020 and 2019, these derivative hedges had a net market value of $ 5.9 million and $ 1.5 million, with notional amounts of $ 246.8 million and $ 284.0 million, respectively. These derivative instruments are included in Investments, other; on the consolidated balance sheets. The fair values of these call options are determined based on quoted market prices from the relevant exchange and are classified as Level 1 in the fair value hierarchy. Although the call options are employed to be effective hedges against our policyholder obligations from an economic standpoint, they do not meet the requirements for hedge accounting under GAAP. Accordingly, the call options are marked to fair value on each reporting date with the change in fair value, plus or minus, included as a component of net investment and interest income. The change in fair value of the call options include the gains or losses recognized at the expiration of the option term and the changes in fair value for open contracts.